2021 ASCCP Scientific Meeting Program

Colleen K. Stockdale, MD, MS is a Clinical Professor and the William C. Keettel Endowed Chair of Obstetrics and Gynecology at the University of Iowa. She is the Director of the Colposcopy and Vulvar Vaginal Disease Clinics, as well as the Obstetrics and Gynecology Residency Program Director. Dr. Stockdale has served as an ASCCP Board Member since 2010 and has served as faculty for several postgraduate courses and clinical meetings in addition to her service on committees. Dr. Stockdale is a past president of ASCCP.

Hope K. Haefner, M.D., is the Harold A. Furlong Professor of Women’s Health in the Department of Obstetrics and Gynecology at the University of Michigan Hospitals in Ann Arbor, Michigan where she received her medical degree. Dr. Haefner completed her obstetrics and gynecology residency at the University of Michigan Medical Center in 1990. She completed a fellowship in gynecologic pathology in 1993. Dr. Haefner is board certified in obstetrics and gynecology. She opened the University of Michigan Center for Vulvar Diseases in 1993. It is one of a few clinics in the United States that specializes in treating these conditions. She has a national and international reputation in this field. She is a specialist in vulvoscopy. She has a particular interest in high grade squamous intraepithelial lesions of the vulva, lichen sclerosus, lichen planus and hidradenitis suppurativa (including skin grafts and flaps for patients with Stage 3 hidradenitis suppurativa). She is the primary author of the Vulvodynia Guideline, published in 2005. Dr. Haefner is active in vulvovaginal disease research. She was a co-investigator on a R01 with Dr. Barbara Reed, the Longitudinal Population-Based Study of Vulvodynia. Dr. Haefner is a past president of ASCCP.

Dr. Kathryn Welch is an Assistant Professor of Obstetrics and Gynecology at the University of Michigan. She is a Michigan native who earned her undergraduate degree at Michigan State University. Dr. Welch then pursued her medical degree at Wayne State University School of Medicine and completed her residency training in Obstetrics and Gynecology at Wayne State University/Detroit Medical Center. Her practice encompasses general obstetrics and gynecology, with a focus on vulvar diseases. 

Cynthia A Rasmussen MD, FACOG, is an obstetrician-gynecologist, and is Director Emerita of the Vulvovaginal Services at Atrius Health in Burlington, MA, USA. She is on the Corresponding Faculty of Harvard Medical School, and is a NAMS Certified Menopause Practitioner. She has been a clinical instructor for Harvard Medical School, Dartmouth Medical School, and Tufts Medical School.

Lisa C. Flowers, MD, is Professor in the Department of Gynecology & Obstetrics at Emory University School of Medicine. Dr. Flowers joined the Emory faculty in 1999. She is active on many national and state committees aimed at improving the quality and delivery of care and service to patients with cervical and breast disease, including work with the American Society for Colposcopy and Cervical Pathology, American College of Obstetrics and Gynecology, and American Cancer Society. Dr. Flowers is a member of Alpha Omega Alpha Honor Society, the American College of Obstetricians and Gynecologists, International Anal Neoplasia Society and is a member and on the Board of Directors of American Society for Colposcopy and Cervical Pathology. She is also on the DHHS/CDC Breast and Cervical Cancer Early Detection and Control Advisory Committee. Dr. Lisa Flowers received her medical degree from Case Western Reserve University School of Medicine, in Cleveland, Ohio. She completed her residency in obstetrics and gynecology at Magee-Women’s Hospital of the University of Pittsburgh Medical Center in 1996. Dr. Flowers is board certified in obstetrics and gynecology. Dr. Flowers’ research interests include treatment for HPV-related disease, HPV and cervical cancer educational programs, and ovarian cancer surveillance for women with breast cancer susceptibility genes. She is currently the Emory Principal Investigator for several clinical trials entailing biomarker discovery, risk assessment and treatment for anal neoplasia. Dr. Flowers serves on the Executive Board of the ASCCP.

Naomi Jay, PhD, NP, RN is a nurse practitioner in the UCSF Dysplasia Clinic. She specializes in the detection and diagnosis of human papillomavirus (HPV) in the anal canal and also helped pioneer the use of the diagnostic tool, colposcope, for HPV-related diseases. Ms. Jay also participates in HPV-related research, including the natural history of HPV-related anal disease in men and women, treatment studies using vaccines, infrared coagulation and traditional Chinese medicine. Ms. Jay completed her undergraduate degree at McGill University in Montreal, Canada. Subsequently, she earned her graduate degree in nursing, specializing in women's health, at the Massachusetts General Hospital Institute of Health Professionals.

Michelle Khan, MD, MPH is a board-certified Ob/Gyn and Clinical Associate Professor in the Department of Obstetrics and Gynecology at Stanford University School of Medicine. She started working in the HPV field in 2003 during a Howard Hughes-National Institutes of Health research fellowship. She completed medical school at Rutgers University – Robert Wood Johnson Medical School, residency in Gynecology/Obstetrics at the Johns Hopkins Hospital, and fellowship in Reproductive Infectious Diseases at the University of California San Francisco. During fellowship she was trained in advanced colposcopy, high-resolution anoscopy (HRA) and treatment of cervical, vulvar, vaginal and anal disease. She is active in ASCCP and IANS teaching national and international courses in colposcopy and HRA and working on guidelines for screening and management of HPV-related diseases. She is an advocate for LGBTQ+ Health and is currently launching the first ever anal dysplasia program at Stanford.

Joel M. Palefsky, MD is an expert in infectious diseases and in cancers associated with these diseases. His expertise includes treating anal dysplasia, a precancerous condition that may lead to anal cancer and that is caused by the human papillomavirus (HPV). Dr. Palefsky studies the biology of HPV and the Epstein-Barr virus, and is active in the development of new treatments. He earned his medical degree at McGill University and completed a fellowship in infectious disease at Stanford University. Dr. Palefsky is founder and president of the International Anal Neoplasia Society and president-elect of the International Papillomavirus Society.

Colleen K. Stockdale, MD, MS is a Clinical Professor and the William C. Keettel Endowed Chair of Obstetrics and Gynecology at the University of Iowa. She is the Director of the Colposcopy and Vulvar Vaginal Disease Clinics, as well as the Obstetrics and Gynecology Residency Program Director. Dr. Stockdale has served as an ASCCP Board Member since 2010 and has served as faculty for several postgraduate courses and clinical meetings in addition to her service on committees. Dr. Stockdale is a past president of ASCCP.

Hope K. Haefner, M.D., is the Harold A. Furlong Professor of Women’s Health in the Department of Obstetrics and Gynecology at the University of Michigan Hospitals in Ann Arbor, Michigan where she received her medical degree. Dr. Haefner completed her obstetrics and gynecology residency at the University of Michigan Medical Center in 1990. She completed a fellowship in gynecologic pathology in 1993. Dr. Haefner is board certified in obstetrics and gynecology. She opened the University of Michigan Center for Vulvar Diseases in 1993. It is one of a few clinics in the United States that specializes in treating these conditions. She has a national and international reputation in this field. She is a specialist in vulvoscopy. She has a particular interest in high grade squamous intraepithelial lesions of the vulva, lichen sclerosus, lichen planus and hidradenitis suppurativa (including skin grafts and flaps for patients with Stage 3 hidradenitis suppurativa). She is the primary author of the Vulvodynia Guideline, published in 2005. Dr. Haefner is active in vulvovaginal disease research. She was a co-investigator on a R01 with Dr. Barbara Reed, the Longitudinal Population-Based Study of Vulvodynia. Dr. Haefner is a past president of ASCCP.

Dr. Kathryn Welch is an Assistant Professor of Obstetrics and Gynecology at the University of Michigan. She is a Michigan native who earned her undergraduate degree at Michigan State University. Dr. Welch then pursued her medical degree at Wayne State University School of Medicine and completed her residency training in Obstetrics and Gynecology at Wayne State University/Detroit Medical Center. Her practice encompasses general obstetrics and gynecology, with a focus on vulvar diseases. 

Cynthia A Rasmussen MD, FACOG, is an obstetrician-gynecologist, and is Director Emerita of the Vulvovaginal Services at Atrius Health in Burlington, MA, USA. She is on the Corresponding Faculty of Harvard Medical School, and is a NAMS Certified Menopause Practitioner. She has been a clinical instructor for Harvard Medical School, Dartmouth Medical School, and Tufts Medical School.

Levi S. Downs, Jr, MD, MS, is a gynecologic oncologist with Health Partners Park Nicollet. Dr. Downs received his medical degree from the University Of Pittsburgh School Of Medicine in Pittsburgh, Pennsylvania. He did his residency in obstetrics and gynecology at Magee-Women’s Hospital at the University of Pittsburgh Medical Center. Dr. Downs completed a fellowship in gynecologic oncology at the University of Minnesota and has a Master of Science degree in clinical research from the University Of Minnesota School of Public Health. Dr. Downs is the Chief Medical Officer of University of Minnesota Physicians and University of Minnesota Health where he partners with team members to coordinate physician lead clinical quality improvement initiatives and physician leadership of clinical operations. Dr. Downs has served as principal investigator for numerous clinical trials investigating ovarian and cervical cancers, chemotherapy, and therapeutic and preventive approaches to HPV related diseases. Among his many awards, Dr. Downs was recipient of the Robert Wood Johnson Foundation's Harold Amos Faculty Development Award. Among other societies Dr. Downs is also a member of the Society of Gynecologic Oncologists and serves on the Executive Board of the ASCCP.

Gypsyamber D’Souza, PhD, MPH is an Associate Professor Epidemiology at the Johns Hopkins Bloomberg School of Public Health, with a joint appointment in the department of International Health and Otolaryngology-Head and Neck Surgery at the Johns Hopkins Sydney Kimmel Comprehensive Cancer center. She has a M.S. in Molecular and cellular biology from the University of Wisconsin-Madison (1999), an MPH in Disease Control (2001) from the University of Texas-Houston, and a PhD in infectious disease epidemiology from Johns Hopkins (2007).

Michelle Khan, MD, MPH is a board-certified Ob/Gyn and Clinical Associate Professor in the Department of Obstetrics and Gynecology at Stanford University School of Medicine. She started working in the HPV field in 2003 during a Howard Hughes-National Institutes of Health research fellowship. She completed medical school at Rutgers University – Robert Wood Johnson Medical School, residency in Gynecology/Obstetrics at the Johns Hopkins Hospital, and fellowship in Reproductive Infectious Diseases at the University of California San Francisco. During fellowship she was trained in advanced colposcopy, high-resolution anoscopy (HRA) and treatment of cervical, vulvar, vaginal and anal disease. She is active in ASCCP and IANS teaching national and international courses in colposcopy and HRA and working on guidelines for screening and management of HPV-related diseases. She is an advocate for LGBTQ+ Health and is currently launching the first ever anal dysplasia program at Stanford.

Philip E. Castle, PhD, MPH, was appointed Director of the Division of Cancer Prevention (DCP) at the National Cancer Institute (NCI) in July 2020. Dr. Castle earned a Ph.D. in Biophysics in 1995 and, in conjunction with his training in the NCI’s Cancer Prevention Fellowship Program, a Master’s in Public Health in 2000, both at The Johns Hopkins University, Baltimore, Maryland. Dr. Castle also rejoins the NCI as a senior investigator in the Division of Cancer Epidemiology and Genetics, focused on discovery, development, and evaluation/validation of new technologies for the prevention of cancer. His professional interests include health disparities, science and translation of cancer prevention strategies, cancer screening, health services research and delivery, epidemiology of HPV and cervical/anogenital cancers, international health, and evidence-based medicine. Dr. Castle is conducting research studies on cancer screening and prevention in Mozambique, Rwanda, and India as well as continuing his work with Kaiser Permanente Northern California.

Walter K. Kinney, MD is an Internist who practiced Gynecologic Oncology in the Permanente Medical Group. He chaired the group of clinicians that has written their Cervical Cancer Screening Guidelines for the past 20 years, which included the initiation of routine cotesting in 2003. With Barbara Fetterman and Dr. Phil Castle, he started the data collection efforts that have informed subsequent Permanente and national screening guideline recommendations.

Electra D. Paskett, PhD became the Marion N. Rowley Professor of Cancer Research at The Ohio State University in 2002. She is the Director of the Division of Cancer Prevention and Control in the College of Medicine, a professor in the Division of Epidemiology in the College of Public Health and the Associate Director for Population Sciences and Program Leader of the Cancer Control Program in the Comprehensive Cancer Center of the Ohio State University (OSU). She is also Director of the Center for Cancer Health Equity at the James Cancer Hospital. Dr. Paskett’s research program is nationally recognized for studying cancer health disparities. The program has four major areas of focus and has evolved to utilize a "team science approach" to understanding and intervening in these problems: energy balance and cancer prevention; promoting the use of early-detection exams; improving access to diagnostic and treatment services; and lymphedema prevention.

Mark S. Schiffman, MD, MPH received an M.D. from the University of Pennsylvania and an M.P.H. in epidemiology from The Johns Hopkins School of Hygiene and Public Health. He joined the NCI as a Staff Fellow in 1983 and, in 1996, was appointed Chief of the Interdisciplinary Studies Section in the Environmental Epidemiology Branch (which later became the HPV Research Group in the Hormonal and Reproductive Epidemiology Branch). He joined the Clinical Genetics Branch in October 2009 to study intensively why HPV is such a powerful carcinogenic exposure, akin to an acquired genetic trait with high penetrance for a cancer phenotype. Dr. Schiffman has studied human papillomavirus (HPV) and cervical cancer for more than 35 years.

Kimberly Levinson, M.D., is an assistant professor in the Johns Hopkins Medicine Department of Gynecology and Obstetrics. Dr. Levinson received her undergraduate degree from Tufts University. She earned her M.D. from the Johns Hopkins University School of Medicine and her M.P.H. from the Johns Hopkins Bloomberg School of Public Health. She completed her medical residency at the Johns Hopkins University School of Medicine and performed a clinical fellowship in gynecologic oncology at Cleveland Clinic. Dr. Levinson has also completed international research at Preventive Oncology International in Peru and the School for International Training in Chile. Dr. Levinson joined the Johns Hopkins faculty in 2014.

Dr. Sara Pai is Associate Professor of Surgery at Harvard Medical School and Director of Translational Head and Neck Cancer Research at Massachusetts General Hospital. She completed the MD/PhD program at Johns Hopkins University School of Medicine in which she obtained her PhD training in cancer immunology and vaccines. After completing her residency in otolaryngology-head and neck surgery at Johns Hopkins Hospital, she joined its faculty in 2007 where she led a therapeutic human papillomavirus (HPV) vaccine clinical trial which was supported by the Head and Neck Cancer SPORE program.

Leslie R. Boyd, MD is an Associate Profession in the Department of Obstetrics and Gynecology at NYU Grossman School of Medicine. She is also the Director of the Gynecologic Oncology Fellowship Program. Dr. Boyd completed her MD from Yale University in 2000, residency in obstetrics and gynecology in 2004 from NYU Langone Medical Center, and following in gynecologic oncology from NYU Langone Medical Center in 2009.

David Chelmow, MD is the Leo J Dunn Professor and Chair of Obstetrics and Gynecology at Virginia Commonwealth University. He complete his MD at Yale University Medical School and Residency at UCSF. Dr. Chelmow is the 2020-2021 ASCCP President-Elect.

Professor Patti E. Gravitt, PhD, MS is a professor in the Department of Epidemiology and Public Health for the University of Maryland School of Medicine in their Division of Preventative Medicine. She earned her PhD in Epidemiology from Johns Hopkins University Bloomberg School of Public Health and her MS in Biology from University of North Carolina, Charlotte.

Rachel Winer, PhD, MPH is a Professor and Director of Research in the Department of Epidemiology at the University of Washington School of Public Health and an Affiliate Scientific Investigator at Kaiser Permanente Washington Health Research Institute. Her research interests are in the epidemiology and prevention of human papillomavirus (HPV) infections and HPV-related cancers. Dr. Winer earned a MPH in Epidemiology (2002) and PhD in Epidemiology (2005) from the University of Washington.

Anne F. Rositch, PhD, MSPH is an applied epidemiologist, concentrating on cancer in women and global cancer disparities, with a background in basic science and experience conducting international field-based research. She received her PhD in Epidemiology from the University of North Carolina at Chapel Hill, and completed a post-doctoral fellowship in Cancer Epidemiology at Johns Hopkins. Currently, Dr. Rositch is an Associate Professor in the Department of Epidemiology at the Johns Hopkins Bloomberg School of Public Health, where co-teaches the first year Doctoral Seminar course, is a mentor on two NIH T32 training grants, and is a co-Director of the Doctoral Program.

Michelle I. Silver, PhD is an Assistant Professor, Department of Surgery, School of Medicine for the Washington University School of Medicine in St. Louis. She earned a PhD in Epidemiology from Johns Hopkins School of Public Health in 2014. Dr. Silver's postdoctoral education includes: Cancer Prevention Fellow, National Cancer Institute, NIH, Division of Cancer Epidemiology and Genetics (2015-2019) and Postdoctoral Research Fellow, Johns Hopkins School of Public Health, Department of Epidemiology (2015).

Anne Hammer, MD, PhD is an Associate Professor, in the Department of Clinical Medicine - Department of Obstetrics and Gynecology, with the Aarhus University in Denmark and a Senior Resident at Herning Regional Hospital. She earned her MD (2009) and PhD in Medicine (2015) from Aarhus University.

Maria DeMarco, PhD, MPH is a Senior Study Director/Epidemiologist with Westat in Rockville, Maryland. She earned her MPH (2011) and PhD (2017) in Epidemiology from the University of Maryland College Park.

Deanna Teoh, M.D., FACS, FACOG, is a gynecologic oncologist in the Division of Gynecologic Oncology, Department of Obstetrics and Gynecology. She graduated summa cum laude from Macalester College (2000) with a Bachelor’s degree in music. She received her M.D. degree from the Medical College of Wisconsin (2004). She completed residency training in Obstetrics & Gynecology at the University of California San Francisco (2008) and then subsequently completed a subspecialty fellowship in Gynecologic Oncology at Duke University (2010). Dr. Teoh joined the Gynecologic Oncology faculty of the Department of Obstetrics, Gynecology and Women’s Health at the University of Minnesota in 2011.

Sangini S. Sheth, MD, MPH, FACOG is an associate professor in the Division of Gynecologic Specialties, Department of OBGYN at Yale School of Medicine. She graduated from Yale University and received her MD and MPH from the Johns Hopkins School of Medicine and Bloomberg School of Public Health. She completed her residency training in obstetrics and gynecology at Johns Hopkins Hospital and joined the faculty at Yale in 2013. Dr. Sheth's clinical and public health backgrounds have guided her research interests in optimizing reproductive health awareness, access, and care among marginalized groups. Her current work focuses on cervical cancer prevention across the care continuum from uptake of the HPV vaccine, to increasing cervical cancer screening and follow up of abnormal results, and guideline-concordant evidence-based management locally and globally.

Robert D. Burk, MD Dr. Burk received his MD from the George Washington University School of Medicine and completed surgical internship at UCSF followed by a residency in pediatrics at UCSF. He then completed a medical genetics fellowship at Johns Hopkins. He is board certified in both pediatrics and medical genetics. His research interests include the natural history of cervical human papillomavirus (HPV), papillomavirus genomics and understanding HPV variation and human disease. He has published over 450 papers in peer-reviewed journals.

Dr. Burk has been a member of the Papillomavirus Study Group of the International Committee on Taxonomy of Viruses (ICTV) for over 20 years and was the past chair of the group. He is a member of the executive board of the International Papillomavirus Society (IPVS). He has been consistently funded by NIH for over 30 years and is an elected Fellow of the AAAS.